Fig. 7From: A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats a Radiographic images at 14 (A-D) and 28 days (E-H) after femoral surgery in non-ovariectomized rats (NOVX). b Radiographic images at 14 (A-D) and 28 days (E-H) after femoral surgery in ovariectomized rats (OVX). A and E (heterologous fibrin sealant treatment); B and F (fibrin sealant (HFS) + mesenchymal stem cells (MSCs) treatment); C and G (HFS + mesenchymal stem cells differentiated into the osteogenic lineage (MSCs D) treatment); D and H (injury, control); I (non-injury, control); Black arrow: injuryBack to article page